BIOFACTORS
Scope & Guideline
Elevating Research Standards in Biochemistry and Medicine
Introduction
Aims and Scopes
- Bioactive Compounds and Their Mechanisms:
Research on the mechanisms of action of various bioactive compounds, including phytochemicals, vitamins, and other natural products, and their roles in health and disease. - Cancer Biology and Therapeutics:
Studies exploring the molecular pathways involved in cancer progression, resistance mechanisms, and the potential of bioactive compounds as therapeutic agents. - Metabolic and Endocrine Disorders:
Investigations into the effects of bioactive substances on metabolic syndromes, obesity, diabetes, and related endocrine disorders. - Neurobiology and Neurodegenerative Diseases:
Research focused on the neuroprotective effects of various compounds and their roles in neurodegenerative diseases such as Alzheimer's and Parkinson's. - Inflammation and Immunomodulation:
Exploring the roles of bioactive compounds in modulating inflammatory responses and their therapeutic implications in chronic diseases. - Microbiome and Gut Health:
Studies examining the interactions between dietary components, gut microbiota, and their influence on overall health and disease outcomes. - Oxidative Stress and Antioxidant Defense:
Research on the role of oxidative stress in disease processes and the therapeutic potential of antioxidants derived from natural sources. - Molecular and Cellular Biology:
Investigations into cellular signaling pathways, gene expression, and the role of non-coding RNAs in various biological processes.
Trending and Emerging
- Personalized Nutrition and Metabolism:
An increasing focus on how individual variations in metabolism affect responses to dietary bioactive compounds, leading to personalized nutrition strategies. - Nanotechnology in Drug Delivery:
Emerging research on the use of nanotechnology to enhance the delivery and efficacy of bioactive compounds in therapeutic applications. - Gut-Brain Axis:
Growing interest in the interactions between gut microbiota and neurological health, highlighting the role of dietary components in influencing brain function. - Plant-Derived Compounds in Chronic Disease Management:
A rising trend in exploring the therapeutic potential of plant-derived compounds in managing chronic diseases such as diabetes, cardiovascular diseases, and cancer. - Immunotherapy and Bioactive Compounds:
Increased exploration of the role of bioactive compounds in enhancing immunotherapeutic approaches for cancer and other diseases. - Epigenetics and Bioactive Compounds:
Emerging research on how bioactive compounds can influence epigenetic mechanisms, potentially affecting gene expression and disease outcomes. - Sustainability and Bioactive Compounds:
A growing emphasis on sustainable sourcing and the environmental impact of bioactive compounds, reflecting a broader trend towards environmentally conscious research.
Declining or Waning
- Traditional Herbal Medicine:
There has been a noticeable decrease in publications focused on traditional herbal medicines and their applications, which may reflect a shift towards more mechanistic and targeted studies involving specific bioactive compounds. - Basic Biochemical Pathways:
Research focusing solely on basic biochemical pathways without direct relevance to health outcomes or therapeutic implications seems to be less frequent, indicating a trend towards more applied research. - Animal Models of Disease:
While animal studies remain vital, there is a waning interest in certain animal model studies, particularly those that do not translate directly to human health or therapeutic strategies. - Epidemiological Studies:
Epidemiological research examining population-level health outcomes related to bioactive compounds appears to be less emphasized in recent issues, possibly overshadowed by more mechanistic studies.
Similar Journals
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
Unveiling the Critical Role of Trace Elements in Human HealthThe JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, published by Elsevier GmbH, stands as a leading platform for disseminating pivotal research in the interdisciplinary field that bridges biochemistry, inorganic chemistry, and molecular medicine. With an impact factor reflective of its high-quality submissions and significant contribution to the scientific community, this journal currently holds a Q2 ranking in Biochemistry and a Q1 ranking in Inorganic Chemistry, underlining its esteemed status among peers. Since its inception in 1995 and continuing through to 2024, the journal has fostered a dynamic discourse on the fundamental roles of trace elements in biological systems, incorporating studies that range from their biochemical functions to their impact on health and disease. Researchers, professionals, and students alike can access a wealth of knowledge, missing Open Access options notwithstanding, making it indispensable for those at the forefront of scientific investigation in medicine and biology.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
Innovating insights in molecular biology and genetics.International Journal of Molecular Medicine is a prestigious publication dedicated to advancing the field of molecular medicine through innovative research and scholarly dialogue. Published by Spandidos Publications Ltd in Greece, this journal has successfully provided a platform for academics and professionals alike since its inception in 1998. With an impressive 2023 Q1 ranking in Medicine (Miscellaneous) and a Q2 ranking in Genetics, the journal maintains a vital role in disseminating high-quality research, underscored by its strong performance in the Scopus rankings, particularly in the realm of genetics where it ranks 28 out of 347. Researchers will benefit from its comprehensive scope, which encompasses a wide range of topics within molecular biology, genetics, and their clinical applications. Although the journal does not operate under an open access model, it remains influential, providing critical insights that contribute significantly to the understanding and development of molecular therapeutic strategies and innovations.
NEUROCHEMISTRY INTERNATIONAL
Driving Progress in Neuroscience Through Rigorous ResearchNEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
Illuminating Pathways in Biochemistry and PhysiologyJOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, published by Springer in the Netherlands, serves as a pivotal platform for disseminating high-quality research within the fields of physiology, biochemistry, and related biomedical sciences. With an impressive impact factor reflected in its categorization as Q2 in Biochemistry and Q1 in Medicine (miscellaneous), this journal fosters a vibrant community of scholars dedicated to advancing knowledge and innovation. The journal’s broad scope encompasses a wide range of topics from cellular mechanisms to systemic physiology, making it relevant for both theoretical and applied sciences. Researchers and practitioners are encouraged to utilize the available Open Access options to reach a wider audience. The journal’s continuous contribution to the scientific dialogue since its inception in 1996 positions it as a key resource for professionals and students alike, facilitating the exploration of cutting-edge topics and collaborative research opportunities.
BIOSCIENCE REPORTS
Your Gateway to Cutting-Edge Scientific DiscoveriesBIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.
MOLECULAR AND CELLULAR BIOLOGY
Pioneering Research in Cell Biology ExcellenceMOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.
CELLULAR & MOLECULAR BIOLOGY LETTERS
Unlocking the Secrets of Life at the Molecular LevelCELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.
METABOLIC BRAIN DISEASE
Exploring the intersection of biochemistry and neurology.METABOLIC BRAIN DISEASE, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to advancing our understanding of the metabolic processes impacting brain health and disease. Established in 1986 and set to continue until 2024, this journal encompasses a wide range of interdisciplinary research that intersects the fields of Biochemistry, Cellular and Molecular Neuroscience, and Neurology, as evidenced by its notable quartile placements in Q2 and Q3 for 2023. With an ISSN of 0885-7490 and an E-ISSN of 1573-7365, it serves as a vital resource for researchers and practitioners aiming to deepen their insights into cerebral metabolic disorders and their implications. Although currently not an Open Access option, its rigorous peer-review process ensures that high-quality, impactful research reaches its audience. Showcasing a significant rank within the top percentile of its categories, METABOLIC BRAIN DISEASE is instrumental in shaping the future of neurological research and clinical applications.
FREE RADICAL RESEARCH
Unveiling the Secrets of Oxidative MechanismsFREE RADICAL RESEARCH, published by TAYLOR & FRANCIS LTD, stands at the forefront of studies in biochemistry and medicine, with a distinguished trajectory since its inception in 1985. This esteemed journal, which boasts an ISSN of 1071-5762 and an E-ISSN of 1029-2470, is recognized for its impactful contributions within the scientific community, as evidenced by its Q2 ranking in the 2023 category quartiles for both Biochemistry and miscellaneous Medicine. Utilizing rigorous peer-review standards, FREE RADICAL RESEARCH disseminates critical findings on the role of free radicals in biological systems, facilitating knowledge exchange among researchers, healthcare professionals, and students. Although it is not an open-access journal, its reach through academic databases ensures visibility and accessibility of groundbreaking research, making it an indispensable resource for those engaged in the dynamic fields of biochemistry and molecular biology. As the journal continues to evolve until 2024, it remains committed to advancing our understanding of oxidative stress and its implications for health and disease.
Frontiers in Bioscience-Landmark
Elevating Knowledge in Biochemistry and BeyondFrontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.